Moreover, HDAC3 is a crucial regulator of PD-L1 transcription in B-cell lymphomas, and its inhibition increases the response to anti-PD-1 therapy33. The gene discussed is HDAC3; the disease is B-cell non-Hodgkin lymphoma.